(12)Furthermore, Article 9(1) of Implementing Regulation (EU) 2021/620 provides that the Member States or zones thereof with disease-free status from infection with bluetongue virus (serotypes 1-24) (infection with BTV) are listed in Part I of Annex VIII to that Implementing Regulation. Commission Implementing Regulation (EU) 2026/293note amended the table set out in Part I of Annex VIII to Implementing Regulation (EU) 2021/620, by listing several zones in Poland as zones without disease-free status with regard to infection with BTV. However, an error has now been detected as these zones still comply with the criteria to maintain the disease-free status with regard to infection with BTV. It is therefore necessary to correct accordingly the entry for Poland in Part I of Annex VIII. Implementing Regulation (EU) 2021/620 should, therefore, be corrected accordingly.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.